37
The drive to reduce antibiotic use and misuse in human medicine had gained considerable 38 traction 2) the proportion of broad-spectrum antibiotics prescribed in primary care. Specifically, the 52 QPP aims to reduce prescriptions of co-amoxiclav, cephalosporins and fluoroquinolones by 53 10% (from each CCG's 2013/14 value) as a percentage of the total number of antibiotics 54 prescribed in primary care, or to be below the 2013/14 median proportion for English CCGs 55 (11.3%), whichever represents the smallest reduction. 56 57
As a result of the QPP, in 2015-16 the NHS of England, for the first time, reduced their 58 prescriptions of antibiotics by 7.3% (37.03 million items to 34.34 million) as compared to 59 2014-15. The NHS also saw a reduction of 16% in broad-spectrum antibiotics (3.94 million 60 items to 3.3 million, inclusive of cephalosporins, co-amoxiclav and quinolones). The goal for 61 2016-17 was set to reduce total antibiotic use by another 4% and 20% for broad-spectrum 62
antibiotics. 63 64
The reduction in antibiotic prescribing in 2015/16 resulted in the use of nearly 3 million fewer 65 antibiotic items, resulting in a proportional reduction in antibiotics released into wastewater. 66 This is because a significant proportion of antibiotics are conserved as they pass through the 67 body before being excreted as a mixture of the parent compound and metabolites in the 68 urine and faeces [3] . The gut bacteria from hundreds of thousands of NHS patients would 69 have been enriched in antibiotic resistance, a phenomenon that is unavoidable upon 70 consumption of antibiotics [4] . It is this chronic release of antibiotic and antibiotic-resistant 71 bacteria from sewage effluent into freshwater that is thought to increase the prevalence of 72 resistance genes in the environment substantially. This is most evident downstream a 73 sewage treatment plant (STP) discharge point as compared to upstream [5] [6] [7] [8] [9] [10] . Recent 74 evidence shows that even trace levels of sewage effluent can elevate the prevalence of 75 markers of antibiotic resistance, i.e., class 1 integrons [11] . 76 77 This study focused on two questions that explore the link between antibiotic use and 78 environmental impact: 79 1) Would reductions in antibiotic use, such as the ones witnessed in England in 80 2015/16, result in a reduction in antibiotic resistance in English sewage-impacted 81 rivers? and 82
2) How much of a reduction in antibiotic use might be required to alleviate the risk 83 posed by sewage effluent on antimicrobial resistance selection in rivers? These are 84 the two questions that this research aims to examine. 85 86
This study focused on two classes of antibiotics: macrolides and fluoroquinolones. Table 1  87 highlights the pharmacokinetics of these classes of antibiotics. These were specifically 88 selected because: 1) they are two of the more persistent classes of antibiotics in the 89 environment; 2) they are found in nearly all antibiotic surveillance studies [12] [13] [14] [15] [16] [17] (Table 2 ) and then moles (Table 3) and subsequently  120 normalised to the population within each CCG ( STPs included in LF2000-WQX (black points) can be seen in Figure 2 . Thus, working from 153 the upstream reaches at the head of the river network to the outlet of the river basin, the 154 model accounts for the accumulation of point antibiotic loads and the water in which these 155 loads are diluted. Degradable chemicals might be removed from STPs and the river water. 156
The latter is represented by a non-specific dissipation process assuming first-order kinetics. 157
To provide a realistic worst-case scenario, antibiotics were assumed to persist in the river for 158 at least one day. 159 160
In summary, LF2000-WQX was parameterised with the highest monthly fluoroquinolone and 161 macrolide prescription rate for each of the four CCGs (see bolded rates in Table 4 ). 162
Macrolide and fluoroquinolone loss was accounted for upon excretion (32.2% and 64.2%, 163 respectively) and before discharge from STPs into the receiving river (50% A sensitivity analysis was conducted to identify the NHS prescribing rate that protects ≥90% 231 of the length of the modelled Thames catchment from macrolide and fluoroquinolone 232 resistance selection. A target of 90% was set instead of 100% as many rivers in England are 233 highly impacted by, or solely composed of, sewage effluent-particularly in headwaters. 234
Hence, a target of 100% is unrealistic and would necessitate even more dramatic reductions 235 in antibiotic use or zero effluent discharge. 236 237
The sensitivity analysis revealed that macrolide prescriptions must decline by 77% to protect 238 90.4% of the length of the Thames catchment from macrolide resistance selection (Table 6 ; 239 Figure 4a ). Even at this much-reduced prescription rate, there were still 13 reaches with a 240 total length of 8.5 km (0.6%) remaining 'critical' for macrolide resistance selection ( Figure  241 4a). Fluoroquinolone prescriptions would need to be reduced by 85% to alleviate the 242 selection risk in 90% of the catchment ( However, if the antibiotics within a class were unevenly reduced, this could delay or hasten 295 the time to achieve 'low risk'. For example, ciprofloxacin is the most 'potent' fluoroquinolone 296 in its class, with a PNEC of 64 ng/L, whereas ofloxacin and norfloxacin are less 'potent', with 297 a PNEC of 500 ng/L. In other words, ciprofloxacin is 7.8125 times more potent than ofloxacin 298 and norfloxacin. Hence, the benefit gained from reducing 1 unit of ciprofloxacin necessitates 299 a reduction in 7.8125 units of ofloxacin or norfloxacin. As ciprofloxacin represents the 300 majority of fluoroquinolone prescribed (96.9%; Spreading the mitigation costs across a range of challenges might also be more politically 444 and socially tractable, owing to the significant cost associated with improving our treatment 445 of wastewater. 446 447
Although not immediately within the scope of this paper, it is relevant to highlight that any 448 engineering solutions employed for the removal of antibiotics from sewage effluent might be 449 ineffective in reducing the DNA pollution that ARGs represent. Co-development of 450 engineering solutions to tackle the chemical and biological drivers of ARGs in the 451 environment is required to reduce the environmental pressure caused by our wastewater. In 452 addition, the 'waste' by-products of STP, sludge, which contains antibiotic resistance, 453 antibiotics and non-antibiotic chemical drivers of resistance are currently amended to land, 454 representing additional risks to humans and the environment [47], but are out of the study's 455 scope. 456 457
Conclusion. This study aims to catalyze a more holistic discussion about antibiotic 458 stewardship and its impact on the environment. The extent to which further reductions in 459 antibiotic prescribing needs to intensify is estimated, and provides an aspirational target for 460 the NHS. A One Health approach to tackling AMR must consider, more broadly, the factors 461 that can limit the environmental selection and dissemination of antibiotic resistance genes, 462 including co-selecting chemicals, e.g., metals, biocides, and their varied sources. 
